Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report
General Material Designation
[Article]
First Statement of Responsibility
Mendelsohn, Rebecca A.; Taveras, Anabelle N.; Mazer, Benjamin A.; Clayton, Lisa M.
SUMMARY OR ABSTRACT
Text of Note
Introduction: Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Less prevalent is euglycemic DKA (eDKA)-DKA with serum glucose less than 200 mg/dL; however, it is increasing in frequency with the introduction of sodium glucose cotransporter 2 (SGLT-2) inhibitors for treatment of type 2 diabetes.
SET
Date of Publication
2020
Title
Clinical Practice and Cases in Emergency Medicine
Volume Number
4/3
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Mendelsohn, Rebecca A.; Taveras, Anabelle N.; Mazer, Benjamin A.; Clayton, Lisa M.